NORTHERN TRUST CORP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 43 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$298,000
+380.6%
846,808
+167.1%
0.00%
Q1 2020$62,000
+3.3%
317,043
+15.7%
0.00%
Q4 2019$60,000
-4.8%
274,0650.0%0.00%
Q3 2019$63,000
-6.0%
274,0650.0%0.00%
Q2 2019$67,000
-49.2%
274,0650.0%0.00%
Q1 2019$132,000
+24.5%
274,0650.0%0.00%
Q4 2018$106,000
-47.8%
274,0650.0%0.00%
Q3 2018$203,000
+198.5%
274,065
+157.6%
0.00%
Q2 2018$68,000
+74.4%
106,3880.0%0.00%
Q1 2018$39,000
-45.1%
106,3880.0%0.00%
Q4 2017$71,000
+16.4%
106,3880.0%0.00%
Q3 2017$61,000
-53.1%
106,3880.0%0.00%
Q2 2017$130,000
-19.3%
106,3880.0%0.00%
Q1 2017$161,000
+192.7%
106,388
+69.4%
0.00%
Q4 2016$55,000
-32.1%
62,800
+4.8%
0.00%
Q3 2016$81,000
-22.1%
59,900
+1.7%
0.00%
Q2 2016$104,000
+14.3%
58,900
+29.2%
0.00%
Q1 2016$91,000
-38.1%
45,5890.0%0.00%
Q4 2015$147,000
+81.5%
45,5890.0%0.00%
Q3 2015$81,000
-87.1%
45,589
-80.8%
0.00%
Q2 2015$629,000
+13.3%
237,358
+5.7%
0.00%
Q1 2015$555,000
-54.6%
224,592
+8.2%
0.00%
Q4 2014$1,222,000
-9.8%
207,568
+2.7%
0.00%
Q3 2014$1,355,000
+400.0%
202,181
+438.8%
0.00%
Q2 2014$271,00037,5220.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 621,840$121,0000.05%
ARDSLEY ADVISORY PARTNERS LP 75,000$15,0000.01%
Summit X, LLC 52,500$10,0000.01%
INTRUST BANK NA 40,000$8,0000.00%
FCG ADVISORS, LLC 37,700$7,0000.00%
Summit Financial Wealth Advisors, LLC 14,000$3,0000.00%
Bank Julius Baer & Co. Ltd, Zurich 241,368$47,0000.00%
Hartford Financial Management Inc. 18,000$3,0000.00%
Rockefeller Capital Management L.P. 25,000$5,0000.00%
DOWLING & YAHNKE LLC 22,870$4,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders